Analysts think AEMD stock price could increase by 798%
Mar 12, 2025, 11:25 AM
-22.87%
What does AEMD do
Aethlon Medical, based in San Diego with 14 employees, develops diagnostic and therapeutic products, including the FDA-designated Hemopurifier for treating advanced cancer and life-threatening viruses.
4 analysts think AEMD stock price will increase by 797.68%. The current median analyst target is $3.95 compared to a current stock price of $0.44. The lowest analysts target is $0.76 and the highest analyst target is $7.35.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
